Online inquiry

IVTScrip™ mRNA-Human CD34, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A))   (CAT#: GTTS-WK3531MR)

This product GTTS-WK3531MR is a type of mRNA having 30 nt poly(A) tail and modified with Cap 0 & 5-Methyl-CTP & Pseudo-UTP. It ecodes the CD34 protein. This product can be used in -related researches.
Specifications
Product type mRNA
Modified bases 5-Methyl-CTP & Pseudo-UTP
5' Cap Cap 0
Species Human
RefSeq NM_001025109.1
Applications Gene therapy research
Format Powder
Quantity 100 µg
Purification oligo-dT affinity purification
Target Gene
Gene ID 947
UniProt ID P28906
Download
Download resources about mRNA therapeutics development to boost your research.
CUSTOMER REVIEWS and Q&As

There are currently no Customer reviews or questions for IVTScrip™ mRNA-Human CD34, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) (GTTS-WK3531MR). Click the button above to contact us or submit your feedback about this product.
See other products
CAT Product Name Product Type CDs
GTTS-WK24157MR IVTScrip™ mRNA-Human ARMC8, (Cap 0, 5-Methoxy-UTP, 30 nt-poly(A)) mRNA ARMC8
GTTS-WK24208MR IVTScrip™ mRNA-Human ASF1A, (Cap 0, 5-Methoxy-UTP, 30 nt-poly(A)) mRNA ASF1A
GTTS-WK26819MR IVTScrip™ mRNA-Human ARHGEF39, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) mRNA ARHGEF39
GTTS-WK15390MR IVTScrip™ mRNA-Human Albumin, (Cap 0, 2-Thio-UTP, 120 nt-poly(A)) mRNA Albumin
GTTS-WK28639MR IVTScrip™ mRNA-Human ARL2BP, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) mRNA ARL2BP
GTTS-WK8827MR IVTScrip™ mRNA-Human ACKR3, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) mRNA ACKR3
GTTS-WK28013MR IVTScrip™ mRNA-Human ARHGEF2, (Cap 1, 2-Thio-UTP, 30 nt-poly(A)) mRNA ARHGEF2
GTTS-WK25900MR IVTScrip™ mRNA-Human ARHGAP45, (Cap 1, 5-Methoxy-UTP, 120 nt-poly(A)) mRNA ARHGAP45
All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
×

Webinar Register

Simone Pinto Carneiro, Ph.D.

Group Leader, Ludwig-Maximilians-University of Munich

date-time 10AM EDT | May 19, 2026

Register Now →